Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-26 @ 2:07 PM
Study NCT ID:
NCT05309304
Status:
COMPLETED
Last Update Posted:
2022-10-12
First Post:
2022-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cefazolin PK Study 3g vs 2g
Sponsor:
Baxter Healthcare Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-14
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-25
First Submit QC Date:
None
Study First Post Date:
2022-04-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-11
Last Update Post Date:
2022-10-12
Last Update Post Date Type:
ACTUAL